Table 1.
The composition of carbamazepine solid lipid nanoparticles formulations.
Formulation No. | Drug (mg) | Type of Lipid | Type of Surfactant | Surfactant% (w/v) | Total Volume (mL) |
---|---|---|---|---|---|
F1 | 10 | Stearic acid | Tween 80 | 0.5% (100 mg) | 20 |
F2 | 10 | Stearic acid | Tween 80 | 1% (200 mg) | 20 |
F3 | 10 | Stearic acid | Poloxamer 188 | 0.5% (100 mg) | 20 |
F4 | 10 | Stearic acid | Poloxamer 188 | 1% (200 mg) | 20 |
F5 | 10 | GMS | Tween 80 | 0.5% (100 mg) | 20 |
F6 | 10 | GMS | Tween 80 | 1% (200 mg) | 20 |
F7 | 10 | GMS | Poloxamer 188 | 0.5% (100 mg) | 20 |
F8 | 10 | GMS | Poloxamer 188 | 1% (200 mg) | 20 |
GMS: glyceryl monostearate.